Hovnanian Enterprises
HOV
111.26
-3.32
-2.90%
Hovnanian Enterprises
US · HOV
#3555 by market cap
111.26
-3.32
-2.90%
Live - 5344 symbols - heartbeat 284s ago
· 2026-10-08 08:33
Pre-market
112.00
+0.67%
After-hours
111.26
0.00%
- Market cap
- 663.10M
- P/E (TTM)i
- 106.98
- P/Bi
- 0.97
- EPSi
- 7.43
- Div yieldi
- 0.00%
- 52W posi
- 35%
Reader sentiment
Are you bullish or bearish on HOV?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Fair
- Altman Z-Score is 2.17, in the 1.8-3.0 "grey zone".
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year -0.88% YoY
Margins
- Gross margin
- 14.12%
- Operating margin
- 2.38%
- Net margin
- 1.72%
Key ratios & quality
- Altman Z-Scorei
- 2.17
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 1.99B | 2.02B | 2.34B | 2.78B | 2.92B | 2.76B | 3.00B | 2.98B |
| Gross profit | 325.36M | 298.60M | 372.21M | 540.80M | 643.43M | 580.14M | 590.23M | 420.67M |
| Selling & admin expenses | 228.83M | 233.15M | 241.81M | 276.59M | 296.15M | 304.77M | 342.23M | 349.84M |
| Research & development | -- | -- | -- | -- | -- | -- | -- | -- |
| Operating profit | 94.95M | 63.89M | 130.40M | 264.22M | 347.28M | 275.36M | 248.01M | 70.83M |
| Pretax profit | 8.15M | -39.67M | 55.40M | 189.86M | 319.75M | 255.95M | 317.09M | 86.09M |
| Tax | 3.63M | 2.45M | 4.48M | -417.96M | 94.26M | 50.06M | 75.08M | 22.22M |
| Net profit | 4.52M | -42.12M | 50.93M | 607.82M | 225.49M | 205.89M | 242.01M | 63.87M |
| Basic EPS | 1 | -7 | 7 | 88 | 30 | 29 | 34 | 8 |
| Diluted EPS | 0.72 | -7.06 | 7.03 | 85.86 | 29.00 | 26.88 | 31.79 | 7.43 |
| Line item | 2025-04 | 2025-07 | 2025-10 | 2026-01 | 2026-04 | 2026-07 |
|---|---|---|---|---|---|---|
| Revenue | 686.47M | 800.58M | 817.90M | 631.95M | 667.65M | 705.75M |
| Gross profit | 107.30M | 106.70M | 100.18M | 90.14M | 98.51M | 92.60M |
| Selling & admin expenses | 80.56M | 90.80M | 91.53M | 84.00M | 84.00M | 86.87M |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | 26.73M | 15.90M | 8.65M | 6.14M | 14.51M | 5.73M |
| Pretax profit | 26.53M | 23.80M | -4.11M | 28.70M | 339.00K | -2.78M |
| Tax | 6.80M | 7.19M | -3.44M | 7.84M | 934.00K | -560.00K |
| Net profit | 19.73M | 16.62M | -667.00K | 20.86M | -595.00K | -2.22M |
| Basic EPS | 3 | 2 | -1 | 3 | 0 | -1 |
| Diluted EPS | 2.43 | 1.99 | -0.51 | 2.62 | -0.46 | -0.70 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 1.35B | 1.53B | 1.54B | 1.61B | 1.90B | 1.82B | 1.89B | 1.95B |
| Cash & ST investments | 187.87M | 130.98M | 262.49M | 245.97M | 326.20M | 434.12M | 209.98M | 272.77M |
| Inventory | 1.08B | 1.29B | 1.20B | 1.25B | 1.52B | 1.35B | 1.64B | 1.64B |
| Total assets | 1.66B | 1.88B | 1.83B | 2.32B | 2.56B | 2.49B | 2.61B | 2.63B |
| Total current liabilities | 176.10M | 218.13M | 246.90M | 526.68M | 549.55M | 495.69M | 494.90M | 497.17M |
| Short-term debt | -- | -- | -- | -- | -- | -- | -- | -- |
| Long-term debt | 1.57B | 1.68B | 1.57B | 1.37B | 1.29B | 1.14B | 986.89M | 930.21M |
| Total liabilities | 2,115,546,000.00 | 2,371,200,000.00 | 2,263,436,000.00 | 2,145,124,000.00 | 2,178,979,000.00 | 1,911,151,000.00 | 1,805,225,000.00 | 1,802,978,000.00 |
| Total equity | -453.50M | -489.78M | -436.09M | 175.38M | 383.05M | 581.79M | 800.35M | 830.94M |
| Retained earnings | -1.18B | -1.23B | -1.18B | -567.23M | -352.41M | -157.20M | 74.14M | 127.33M |
| Line item | 2025-04 | 2025-07 | 2025-10 | 2026-01 | 2026-04 | 2026-07 |
|---|---|---|---|---|---|---|
| Total current assets | 1.85B | 1.88B | 1.95B | 2.04B | 2.09B | 2.10B |
| Cash & ST investments | 73.98M | 146.59M | 272.77M | 339.91M | 310.93M | 249.09M |
| Inventory | 1.74B | 1.69B | 1.64B | 1.65B | 1.72B | 1.79B |
| Total assets | 2.55B | 2.63B | 2.63B | 2.73B | 2.83B | 2.86B |
| Total current liabilities | 476.69M | 489.52M | 497.17M | 628.62M | 676.16M | 734.88M |
| Short-term debt | -- | -- | -- | -- | -- | -- |
| Long-term debt | 942.37M | 915.45M | 930.21M | 929.86M | 934.60M | 934.90M |
| Total liabilities | 1,732,729,000.00 | 1,793,989,000.00 | 1,802,978,000.00 | 1,897,042,000.00 | 2,001,231,000.00 | 2,040,102,000.00 |
| Total equity | 820.37M | 835.36M | 830.94M | 837.63M | 827.59M | 820.96M |
| Retained earnings | 116.72M | 130.66M | 127.33M | 145.52M | 142.56M | 138.09M |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -66.82M | -249.13M | 292.83M | 210.21M | 89.47M | 435.28M | 23.64M | 188.28M |
| Depreciation & amortization | 3.16M | 4.17M | 5.30M | 5.28M | 5.46M | 8.80M | 7.73M | 13.86M |
| Free cash flow | -72.02M | -253.13M | 289.45M | 204.27M | 76.87M | 416.45M | 5.78M | 166.18M |
| Dividends paid | -- | 0 | 0 | -818.00K | -11.46M | -10.68M | -10.68M | -10.68M |
| Stock buybacks / issuance | -- | -- | 0 | 0 | -12.22M | -4.80M | -26.53M | -30.24M |
| Ending cash balance | 232.99M | 182.27M | 309.46M | 311.40M | 382.19M | 477.52M | 266.76M | 318.65M |
| Line item | 2025-04 | 2025-07 | 2025-10 | 2026-01 | 2026-04 | 2026-07 |
|---|---|---|---|---|---|---|
| Operating cash flow | 22.30M | 52.78M | 169.07M | 140.89M | -67.10M | -24.03M |
| Depreciation & amortization | 3.02M | 3.19M | 5.35M | 3.27M | 3.54M | 3.72M |
| Free cash flow | 15.98M | 45.77M | 163.99M | 132.12M | -70.45M | -27.87M |
| Dividends paid | -2.67M | -2.67M | -2.67M | -2.67M | -2.67M | -2.67M |
| Stock buybacks / issuance | -12.35M | 94.00K | 58.00K | -9.00M | -9.55M | 78.00K |
| Ending cash balance | 119.22M | 194.81M | 318.65M | 377.79M | 350.39M | 290.97M |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | -- | -- | -- | -- | 135.81 | 51.63 | 40.10 | 7.53 |
| ROA %i | 0.24 | -2.38 | 2.50 | 26.53 | 7.99 | 7.09 | 8.74 | 1.96 |
| ROIC %i | -- | -- | -- | -- | 15.38 | 14.23 | 15.20 | 4.73 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 5.60 | 2.50 | 6.79 | 9.62 | 12.56 | 11.25 | 11.58 | 4.08 |
| FCF / sales %i | -- | -- | 12.35 | 7.34 | 2.63 | 15.11 | 0.19 | 5.58 |
| Current ratioi | 7.68 | 7.03 | 6.26 | 3.06 | 3.45 | 3.67 | 3.82 | 3.92 |
| Quick ratioi | 1.27 | 0.81 | 1.20 | 0.54 | 0.66 | 0.93 | 0.48 | 0.60 |
| Debt / assetsi | 94.49 | 89.48 | 86.86 | 59.19 | 50.40 | 45.85 | 37.88 | 35.32 |
| LT debt / equityi | -- | -- | -- | 3,468.51 | 521.26 | 256.03 | 148.39 | 133.72 |
| Interest coveragei | 1.08 | 0.56 | 1.53 | 3.44 | 7.75 | 5.73 | 11.31 | 3.43 |
| Revenue CAGR (3Y) %i | -2.50 | -9.84 | -1.49 | 11.80 | 13.16 | 5.55 | 2.59 | 0.64 |
| Net income CAGR (3Y) %i | -- | -- | -- | 412.32 | -- | 59.30 | -26.43 | -34.33 |
| FCF CAGR (3Y) %i | -- | -- | -0.64 | -- | -- | 12.89 | -69.53 | 29.30 |
| Line item | 2025-04 | 2025-07 | 2025-10 | 2026-01 | 2026-04 | 2026-07 |
|---|---|---|---|---|---|---|
| ROE %i | 33.24 | 22.55 | 7.53 | 6.41 | 3.53 | 0.98 |
| ROA %i | 8.17 | 5.53 | 1.96 | 1.68 | 0.90 | 0.25 |
| ROIC %i | 14.05 | 10.42 | 4.73 | 4.43 | 3.38 | 2.63 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 10.17 | 7.61 | 4.08 | 3.85 | 3.09 | 2.40 |
| FCF / sales %i | -- | 3.62 | 5.58 | 12.19 | 9.30 | 7.01 |
| Current ratioi | 3.88 | 3.84 | 3.92 | 3.24 | 3.09 | 2.86 |
| Quick ratioi | 0.21 | 0.36 | 0.60 | 0.60 | 0.53 | 0.41 |
| Debt / assetsi | 36.91 | 34.82 | 35.32 | 34.00 | 33.04 | 32.68 |
| LT debt / equityi | 137.56 | 130.77 | 133.72 | 132.75 | 135.53 | 136.81 |
| Interest coveragei | 10.39 | 7.74 | 3.43 | 2.97 | 2.18 | 1.49 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Lead segment, long tail
- Homebuilding - West is the largest reported line at 50.31% of revenue, across 4 reported segments.
- Homebuilding - Northeast follows at 33.06%, so the top line still matters most but isn’t the whole story.
Revenue breakdown most recent period
Business
Homebuilding - West50.31%
Homebuilding - Northeast33.06%
Homebuilding - Southeast13.27%
Financial services3.36%
Quote time 2026-10-08 08:33:53 · For reference only, not investment advice and not tailored to your situation.